Extensive review of the key health apps to prescribe to patients based on their disease pathology and their health needs.
Smartquit is now available for Spanish speaking patients.
Grant supports 2,000 person trial evaluating the SmartQuit app for smoking cessation.
SmartQuit is marketed as the first smoking cessation app proven by a clinical trial.
In a pilot study, Seattle-based 2Morrow Inc’s SmartQuit app demonstrated efficacy in a help people quit smoking. Often, the biggest challenge in getting someone to quit is not the chemical addiction – its the behavioral addiction. For that reason, smoking cessation may be an area where mobile technology is uniquely positioned to make a significant impact. With preliminary data in hand, 2Morrow Inc has received a $250,000 grant from the Washington Life Sciences Discovery Fund. Additionally, they have reached an exclusive licensing agreement with the Fred Hutchinson Cancer Research Center in Seattle.